Gene · 540
Papers3,770
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,770
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat. | Oncol Rep | 2026 | 41268611 | PubTator, text mining | PubMed |
| Motor stereotypies, Dhat syndrome, and gaming disorder: A masquerading presentation of Wilson's disease. | Trop Doct | 2026 | 41259374 | PubTator, text mining | PubMed |
| Nuances in ATP7B Genetic Testing and Interpretation in India. | J Clin Exp Hepatol | 2026 | 41256908 | PubTator, text mining | PubMed |
| From Radiocopper to Cold Copper: Mechanistic Modeling and Simulation to Define Clinical Response Criteria and Biomarkers for VTX-801 in Wilson Disease. | CPT Pharmacometrics Syst Pharmacol | 2026 | 41251113 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in multiple myeloma. | Transl Oncol | 2026 | 41240503 | PubTator, text mining | PubMed |
| Copper in Human Health and Disease: Insights from Inherited Disorders. | Physiology (Bethesda) | 2026 | 41213165 | PubTator, text mining | PubMed |
| Multiple Genetic Analysis Unravels Pseudoexon in ATP7B in a Patient with Clinically Diagnosed Wilson Disease. | Mov Disord Clin Pract | 2026 | 41211777 | PubTator, text mining | PubMed |
| ATPase copper transporting beta contributes to cisplatin resistance as a regulatory factor of extracellular vesicles in head and neck squamous cell carcinoma. | Cancer Gene Ther | 2026 | 41107546 | PubTator, text mining | PubMed |
| The pathogenesis of liver fibrosis in Wilson's disease: hepatocyte injury and regulation mediated by copper metabolism dysregulation. | Biometals | 2026 | 41006805 | PubTator, text mining | PubMed |
| Combined clinical and genomic analysis uncovers neonatal-onset Wilson disease in two siblings with idiopathic cholestasis. | Clin Chim Acta | 2026 | 40818735 | PubTator, text mining | PubMed |
| A metabolic perspective on cuproptosis. | Trends Endocrinol Metab | 2026 | 40681425 | PubTator, text mining | PubMed |
| Lactate metabolism regulating nanosystem synergizes cuproptosis and ferroptosis to enhance cancer immunotherapy. | Biomaterials | 2026 | 40680708 | PubTator, text mining | PubMed |
| Clinical significance and immune microenvironment association of cuproptosis-related genes in pan-cancer. | Exp Physiol | 2026 | 40560740 | PubTator, text mining | PubMed |
| Wilson's Disease with Lymphoproliferative Disorder: A Case Report. | JNMA J Nepal Med Assoc | 2025 | 41766828 | PubTator, text mining | PubMed |
| Pilot Study of Preconception Carrier Screening in Russia: Initial Findings and Challenges. | Genes (Basel) | 2025 | 41595422 | PubTator, text mining | PubMed |
| Clinical and Molecular Analysis of ATP7B Variants Identified by Next-Generation Sequencing in Iraqi Adults With Wilson Disease. | Sultan Qaboos Univ Med J | 2025 | 41536511 | PubTator, text mining | PubMed |
| LRPPRC-Driven Oxidative Phosphorylation Is Associated with Elesclomol-Induced Cuproptosis in Ovarian Cancer. | Int J Mol Sci | 2025 | 41516324 | PubTator, text mining | PubMed |
| Editorial: CRISPR-Based Genome Editing in Translational Research-2nd Edition. | Cells | 2025 | 41511319 | PubTator, text mining | PubMed |
| Mitochondrial dysfunction in Wilson disease: a systematic review and meta-analysis across human and animal models. | Front Mol Biosci | 2025 | 41480142 | PubTator, text mining | PubMed |
| WES-Based Screening of a Swedish Patient Series with Parkinson's Disease. | Genes (Basel) | 2025 | 41465155 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/540/papers?page=7